Your browser doesn't support javascript.
loading
Targeting of the COX-2/PGE2 axis enhances the antitumor activity of T7 peptide in vitro and in vivo.
Yang, Jianrong; Zhong, Jingtao; Zhou, Mi; Zhou, Yinghong; Xiu, Peng; Liu, Feng; Wang, Fuhai; Li, Zelun; Tang, Yuntian; Chen, Yuanyuan; Yao, Siyang; Huang, Tao; Liu, Tianqi; Dong, Xiaofeng.
Affiliation
  • Yang J; Department of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Zhong J; Department of Hepatobiliary Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Zhou M; Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Zhou Y; School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan, China.
  • Xiu P; Department of General Surgery, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
  • Liu F; Department of General Surgery, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
  • Wang F; Department of General Surgery, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
  • Li Z; Department of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Tang Y; Department of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Chen Y; Department of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Yao S; Department of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Huang T; Department of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Liu T; Department of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Dong X; Department of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Drug Deliv ; 28(1): 844-855, 2021 Dec.
Article in En | MEDLINE | ID: mdl-33928829

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Dinoprostone / Carcinoma, Hepatocellular / Collagen Type IV / Cyclooxygenase 2 Inhibitors / Meloxicam / Liver Neoplasms Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Drug Deliv Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Dinoprostone / Carcinoma, Hepatocellular / Collagen Type IV / Cyclooxygenase 2 Inhibitors / Meloxicam / Liver Neoplasms Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Drug Deliv Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Type: Article Affiliation country: China